DOPAMINE
By :- Dr. Manan Parmar
1st Year PG resident
M.G.M. Medical College, Indore
DOPAMINE
Definition
Dopamine is a
neurotransmitter involved
in central and peripheral
nervous system functions.
Synthesis
Synthesized from tyrosine
via the intermediate L-
DOPA.
Metabolism
Metabolized by MAO and
COMT into 3-MT and
DOPAC.
DOPAMINE PATHWAYS IN THE BRAIN
1 Nigrostriatal Pathway
Controls motor functions;
degeneration leads to Parkinson's
disease.
2 Mesolimbic Pathway
Involved in reward, pleasure, and
addiction; hyperactivity implicated in
schizophrenia.
3 Mesocortical Pathway
Involved in cognition, motivation,
and emotional responses;
hypoactivity implicated in negative
symptoms of schizophrenia.
4 Tuberoinfundibular Pathway
Regulates prolactin secretion;
dopamine inhibits prolactin release.
DOPAMINE RECEPTORS
D1-like Receptors
Stimulate adenylyl
cyclase, increasing
cAMP.
D2-like Receptors
Inhibit adenylyl
cyclase, decreasing
cAMP.
Receptor Functions
Motor control,
reward, cognition,
endocrine regulation.
DOPAMINE RECEPTORS - FUNCTIONS
• Motor Function: D1 and D2 receptors regulate voluntary movement;
dysfunction leads to disorders like Parkinson's disease.
• Reward and Reinforcement: D1-like receptors in the mesolimbic
pathway mediate pleasure and motivation.
• Cognition: D1-like receptors are involved in working memory and
decision-making processes.
• Endocrine Regulation: D2 receptors inhibit prolactin release from the
pituitary gland.
PERIPHERAL ACTIONS OF DOPAMINE
Kidneys
Dopamine receptors
control renal blood
flow and sodium
excretion, helping to
maintain healthy
blood pressure.
Cardiovascul
ar System
Cardiac dopamine
receptors modulate
heart rate and
contractility, it
increases cardiac
output but there is no
change in the mean
blood pressure.
Gastrointesti
nal Tract
Dopamine influences
gut motility and
secretion.
Endocrine System
Dopamine inhibits
the release of
prolactin from the
pituitary gland,
regulating important
hormonal processes.
CLINICAL RELEVANCE
PARKINSON'S DISEASE
Medications like levodopa, dopamine
agonists, COMT inhibitors, and MAO-B
inhibitors are used to manage the
symptoms of Parkinson's disease.
SCHIZOPHRENIA
Typical and atypical antipsychotics target
D2 receptors to help manage the positive
symptoms of schizophrenia.
CLINICAL RELEVANCE
1) Neurological Bias
2) Reward pathway
3) Treatment Strategy
4) Neurobiology of Addiction :- A) Mesolimbic dopamine system
B) Reward Circuit
C) Neuro-adaptation
D) Treatment
ADDICTION
CLASSIFICATION OF DOPAMINE AGONISTS
Ergot Derivatives
Drugs like Bromocriptine and
Cabergoline.
Non-Ergot Derivatives
Pramipexole, Ropinirole, and
Rotigotine.
DOPAMINE AGONISTS
Mechanism of Action
Activate dopamine receptors directly.
Uses
Parkinson's Disease, Restless Legs
Syndrome, Prolactinomas,
Hyperprolactinemia, Hypotension,
and Neurological/Psychiatric
Disorders, Tourette's
syndrome and Huntington Chorea.
DOPAMINE AGONISTS - SIDE EFFECTS
Common Side Effects
Nausea, vomiting, dizziness,
orthostatic hypotension.
Serious Side Effects
Hallucinations, impulse control disorders.
CLASSIFICATION OF DOPAMINE ANTAGONISTS
First-Generation
Antipsychotics
Haloperidol,
Chlorpromazine
Second-Generation
Antipsychotics
Risperidone,
Olanzapine,
Quetiapine,
Aripiprazole
Other Dopamine
Antagonists
Metoclopramide,
Prochlorperazine,
Domperidone
DOPAMINE ANTAGONISTS
• Mechanism of Action: Block dopamine receptors, reducing
dopaminergic activity.
• Uses: Antipsychotic Treatment, Antiemetic Treatment,
Hyperprolactinemia, Management of Tourette Syndrome,
Hyperactivity and Agitation, Hypertension.
DOPAMINE ANTAGONISTS - DRUGS AND USES
First-Generation
Antipsychotics
Haloperidol is a typical
antipsychotic primarily used in
the treatment of schizophrenia.
Chlorpromazine is used in
schizophrenia and as an
antiemetic.
Second-Generation
Antipsychotics
Risperidone is used in
schizophrenia and bipolar
disorder. Olanzapine,
Quetiapine and Aripiprazole are
used in schizophrenia, bipolar
disorder, and depression.
Other Uses
Metoclopramide and
Prochlorperazine are used as
antiemetics. Domperidone is a
prokinetic agent and antiemetic.
POTENTIAL SIDE EFFECTS OF
DOPAMINE ANTAGONISTS
Sedation Weight Gain Tardive
Dyskinesia
Neuroleptic
Malignant
Syndrome
DOPAMINE REGULATION: A CRITICAL ROLE
Vital Neurotransmitter
Dopamine has far-reaching effects on
motor function, reward, cognition, and
emotion.
Careful Modulation
Pharmacological agents are crucial for
treating neurological and psychiatric
disorders.
Complexity Requires
An individualized treatment approach
with close patient monitoring.
Optimize Outcomes
Adjust medication regimens to minimize
side effects.
THANK YOU

More Related Content

PPTX
Dopamine
PPTX
Pharmacology of dopamine
PPTX
Neuro-humoral-Transmission-of-Dopamine[1].pptx
PPTX
Class antipsychotics
PPTX
Dopaminegic receptors
PPT
Antipsychotics
PPT
7) DRUG THERAPY FOR PARKINSONISM.ppt
PPTX
CNS and Antidepressants.pptx by ondiek moses from MKU Medical school
Dopamine
Pharmacology of dopamine
Neuro-humoral-Transmission-of-Dopamine[1].pptx
Class antipsychotics
Dopaminegic receptors
Antipsychotics
7) DRUG THERAPY FOR PARKINSONISM.ppt
CNS and Antidepressants.pptx by ondiek moses from MKU Medical school

Similar to Dopamine - monoamines presentation part 1 (20)

PPTX
CNS Disorders
PPTX
Parkinsons disease
PPTX
Parkinson's disease
PPTX
Antiparkinsonian Drugs
PPT
Neurotransmitter - Dopamine
PPTX
Monoamine Neurotransmitters-2.pptx
PPT
Drug addiction neurobiology
PPTX
Antiparkinson's Drugs
PPTX
antipsychoticsagents-210722102024.pptx..
PPTX
Antipsychotics presentation
PPTX
Antipsychotic Medications
PPT
Dopamine Receptors by Manisha
PPT
Neuroleptics and Tranquilazers
PPTX
Antipsychotics agents
PPTX
Antiparkinsonian drugs their Mechanism of action, Pharmacokinetics and their ...
PPTX
Case study of schizophrenia
PPT
3- Antipsychotic agents.ppt
PPTX
antipsychotic medications and classification and uses
PPTX
NEUROTRANSMITTERS 1.pptx
PPTX
antipsychotic drug notes presented by Bangladesh medical college
CNS Disorders
Parkinsons disease
Parkinson's disease
Antiparkinsonian Drugs
Neurotransmitter - Dopamine
Monoamine Neurotransmitters-2.pptx
Drug addiction neurobiology
Antiparkinson's Drugs
antipsychoticsagents-210722102024.pptx..
Antipsychotics presentation
Antipsychotic Medications
Dopamine Receptors by Manisha
Neuroleptics and Tranquilazers
Antipsychotics agents
Antiparkinsonian drugs their Mechanism of action, Pharmacokinetics and their ...
Case study of schizophrenia
3- Antipsychotic agents.ppt
antipsychotic medications and classification and uses
NEUROTRANSMITTERS 1.pptx
antipsychotic drug notes presented by Bangladesh medical college
Ad

More from TasneemHussain14 (15)

PPTX
Progestins-and-Hormone-Modulators..........
PPTX
Gonadotropins-Estrogens-and-Progestins...
PDF
preprobiotics-141014183151-conversion-gate01.pdf
PPTX
Barrier method of Contraception by Dr. Tasneem
PPTX
Antihelminthic_Drugs_Presentation by Dr. Tasneem
PPTX
Anti-Cancer-Drugs presentation by Dr. Tasneem
PPTX
Glucocorticoids presentation by Dr. Tasneem
PPTX
Non steroidal anti inflammatory drugs by Dr. Tasneem
PPTX
Journal presentation on Hypertension and post-operative pain
PPTX
CSI clinical practice guidelines for dyslipidemia management.pptx
PPTX
clinicaltrialsbasketumbrellaplatform.pptx
PPTX
introduction to pharmacology by Dr. Tasneem Attarwala
PPTX
medication errors by Dr. Tasneem Attarwala
PPTX
antiplatelet drugs by- Dr. Tasneem Attarwala
PPTX
Pharmacotherapy of Affective Disorders - Dr. Tasneem Attarwala.pptx
Progestins-and-Hormone-Modulators..........
Gonadotropins-Estrogens-and-Progestins...
preprobiotics-141014183151-conversion-gate01.pdf
Barrier method of Contraception by Dr. Tasneem
Antihelminthic_Drugs_Presentation by Dr. Tasneem
Anti-Cancer-Drugs presentation by Dr. Tasneem
Glucocorticoids presentation by Dr. Tasneem
Non steroidal anti inflammatory drugs by Dr. Tasneem
Journal presentation on Hypertension and post-operative pain
CSI clinical practice guidelines for dyslipidemia management.pptx
clinicaltrialsbasketumbrellaplatform.pptx
introduction to pharmacology by Dr. Tasneem Attarwala
medication errors by Dr. Tasneem Attarwala
antiplatelet drugs by- Dr. Tasneem Attarwala
Pharmacotherapy of Affective Disorders - Dr. Tasneem Attarwala.pptx
Ad

Recently uploaded (20)

PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Reading between the Rings: Imaging in Brain Infections
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PPTX
Neonate anatomy and physiology presentation
PPTX
Post Op complications in general surgery
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
OSCE Series ( Questions & Answers ) - Set 6.pdf
PEADIATRICS NOTES.docx lecture notes for medical students
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
y4d nutrition and diet in pregnancy and postpartum
neurology Member of Royal College of Physicians (MRCP).ppt
Reading between the Rings: Imaging in Brain Infections
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Electrolyte Disturbance in Paediatric - Nitthi.pptx
nephrology MRCP - Member of Royal College of Physicians ppt
Introduction to Medical Microbiology for 400L Medical Students
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Wheat allergies and Disease in gastroenterology
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
Neonate anatomy and physiology presentation
Post Op complications in general surgery
OSCE Series Set 1 ( Questions & Answers ).pdf
09. Diabetes in Pregnancy/ gestational.pptx
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha

Dopamine - monoamines presentation part 1

  • 1. DOPAMINE By :- Dr. Manan Parmar 1st Year PG resident M.G.M. Medical College, Indore
  • 2. DOPAMINE Definition Dopamine is a neurotransmitter involved in central and peripheral nervous system functions. Synthesis Synthesized from tyrosine via the intermediate L- DOPA. Metabolism Metabolized by MAO and COMT into 3-MT and DOPAC.
  • 3. DOPAMINE PATHWAYS IN THE BRAIN 1 Nigrostriatal Pathway Controls motor functions; degeneration leads to Parkinson's disease. 2 Mesolimbic Pathway Involved in reward, pleasure, and addiction; hyperactivity implicated in schizophrenia. 3 Mesocortical Pathway Involved in cognition, motivation, and emotional responses; hypoactivity implicated in negative symptoms of schizophrenia. 4 Tuberoinfundibular Pathway Regulates prolactin secretion; dopamine inhibits prolactin release.
  • 4. DOPAMINE RECEPTORS D1-like Receptors Stimulate adenylyl cyclase, increasing cAMP. D2-like Receptors Inhibit adenylyl cyclase, decreasing cAMP. Receptor Functions Motor control, reward, cognition, endocrine regulation.
  • 5. DOPAMINE RECEPTORS - FUNCTIONS • Motor Function: D1 and D2 receptors regulate voluntary movement; dysfunction leads to disorders like Parkinson's disease. • Reward and Reinforcement: D1-like receptors in the mesolimbic pathway mediate pleasure and motivation. • Cognition: D1-like receptors are involved in working memory and decision-making processes. • Endocrine Regulation: D2 receptors inhibit prolactin release from the pituitary gland.
  • 6. PERIPHERAL ACTIONS OF DOPAMINE Kidneys Dopamine receptors control renal blood flow and sodium excretion, helping to maintain healthy blood pressure. Cardiovascul ar System Cardiac dopamine receptors modulate heart rate and contractility, it increases cardiac output but there is no change in the mean blood pressure. Gastrointesti nal Tract Dopamine influences gut motility and secretion. Endocrine System Dopamine inhibits the release of prolactin from the pituitary gland, regulating important hormonal processes.
  • 7. CLINICAL RELEVANCE PARKINSON'S DISEASE Medications like levodopa, dopamine agonists, COMT inhibitors, and MAO-B inhibitors are used to manage the symptoms of Parkinson's disease. SCHIZOPHRENIA Typical and atypical antipsychotics target D2 receptors to help manage the positive symptoms of schizophrenia.
  • 8. CLINICAL RELEVANCE 1) Neurological Bias 2) Reward pathway 3) Treatment Strategy 4) Neurobiology of Addiction :- A) Mesolimbic dopamine system B) Reward Circuit C) Neuro-adaptation D) Treatment ADDICTION
  • 9. CLASSIFICATION OF DOPAMINE AGONISTS Ergot Derivatives Drugs like Bromocriptine and Cabergoline. Non-Ergot Derivatives Pramipexole, Ropinirole, and Rotigotine.
  • 10. DOPAMINE AGONISTS Mechanism of Action Activate dopamine receptors directly. Uses Parkinson's Disease, Restless Legs Syndrome, Prolactinomas, Hyperprolactinemia, Hypotension, and Neurological/Psychiatric Disorders, Tourette's syndrome and Huntington Chorea.
  • 11. DOPAMINE AGONISTS - SIDE EFFECTS Common Side Effects Nausea, vomiting, dizziness, orthostatic hypotension. Serious Side Effects Hallucinations, impulse control disorders.
  • 12. CLASSIFICATION OF DOPAMINE ANTAGONISTS First-Generation Antipsychotics Haloperidol, Chlorpromazine Second-Generation Antipsychotics Risperidone, Olanzapine, Quetiapine, Aripiprazole Other Dopamine Antagonists Metoclopramide, Prochlorperazine, Domperidone
  • 13. DOPAMINE ANTAGONISTS • Mechanism of Action: Block dopamine receptors, reducing dopaminergic activity. • Uses: Antipsychotic Treatment, Antiemetic Treatment, Hyperprolactinemia, Management of Tourette Syndrome, Hyperactivity and Agitation, Hypertension.
  • 14. DOPAMINE ANTAGONISTS - DRUGS AND USES First-Generation Antipsychotics Haloperidol is a typical antipsychotic primarily used in the treatment of schizophrenia. Chlorpromazine is used in schizophrenia and as an antiemetic. Second-Generation Antipsychotics Risperidone is used in schizophrenia and bipolar disorder. Olanzapine, Quetiapine and Aripiprazole are used in schizophrenia, bipolar disorder, and depression. Other Uses Metoclopramide and Prochlorperazine are used as antiemetics. Domperidone is a prokinetic agent and antiemetic.
  • 15. POTENTIAL SIDE EFFECTS OF DOPAMINE ANTAGONISTS Sedation Weight Gain Tardive Dyskinesia Neuroleptic Malignant Syndrome
  • 16. DOPAMINE REGULATION: A CRITICAL ROLE Vital Neurotransmitter Dopamine has far-reaching effects on motor function, reward, cognition, and emotion. Careful Modulation Pharmacological agents are crucial for treating neurological and psychiatric disorders. Complexity Requires An individualized treatment approach with close patient monitoring. Optimize Outcomes Adjust medication regimens to minimize side effects.